Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers

Clinical trial NCT01563471 · COMPLETED

Trial details

NCT number: NCT01563471
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A With Inhibitors Haemophilia B With Inhibitors Healthy

Start date: 2001-10-01
Primary completion: 2002-07-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.